BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities

スポンサーリンク

概要

論文の詳細を見る
2011-01-10

著者

YEH Teng-Kuang
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
Chao Yu-sheng
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Yeh Teng-kuang
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Chen Chiung-tong
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Chang Ling
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Chang Kai-yen
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Huang Chen-lung
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
HU Chih-Bo
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
CHEN Ching-Ping
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
SONG Jen-Shin
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
CHANG Chi-Yen
National Institute of Cancer Research, National Health Research Institutes
CHUU Jiunn-Jye
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
TUNG Fei-Feng
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
HO Pei-Yin
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
CHEN Tung-Wei
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
LIN Chi-Hung
Institute of Biophotonics, National Yang Ming University
WANG Min-Hsien
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
LIN Heng-Liang
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
LI Wen-Tai
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
HWANG Der-Ren
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
CHERN Jyh-Haur
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes
HWANG Ling-Ling
Graduate Institute of Medical Sciences, School of Medicine, Taipei Medical University
CHANG Jang-Yang
National Institute of Cancer Research, National Health Research Institutes
Wang Min-hsien
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Ho Pei-yin
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Li Wen-tai
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Tung Fei-feng
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Hwang Der-ren
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Chen Tung-wei
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Chern Jyh-haur
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Hwang Ling-ling
Graduate Institute Of Medical Sciences School Of Medicine Taipei Medical University
Chang Jang-yang
National Institute Of Cancer Research National Health Research Institutes
Hu Chih-bo
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Chuu Jiunn-jye
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Lin Heng-liang
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes
Song Jen-shin
Division Of Biotechnology And Pharmaceutical Research National Health Research Institutes

関連論文

スポンサーリンク